People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Other Health Care, Healthtech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RESTOR3D, Inc. | — | Other Health Care | Series C | $239.2M | $522.0M | 2017 |
| CurvaFix, Inc. | — | Other Health Care | Series C | $50.7M | $477.8M | 2023 |
| Huxley Medical, Inc. | — | Healthtech | Series A | $32.7M | $29.7M | 2024 |
| Synaptrix, Inc. | — | Other Technology | Series A | $10.0M | $47.9M | 2024 |
| Nanochon, Inc. | — | Other Technology | Seed | $9.6M | $9.0M | 2023 |
Kurt Jacobus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kurt Jacobus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Gall | 2 | 5 |
| Michael Porter | 2 | 3 |
| Christopher Lee | 1 | 9 |
| Andrew Miller | 1 | 8 |
| Eric Bell | 1 | 7 |
| Mark Foster | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| Doug Reed | 1 | 6 |
| Trevor Moody | 1 | 5 |
| Chris Lee | 1 | 5 |
| Robert Crutchfield | 1 | 5 |
| Robert Creeden | 1 | 4 |
| Benjamin Holmes | 1 | 4 |
| Ken Gall | 1 | 4 |
| Douglas Kohrs | 1 | 4 |
| ANDREW SUMMERS | 1 | 3 |
| Sean Churchill | 1 | 3 |
| JAMES STUBBS | 1 | 3 |
| Steven Dimmer | 1 | 2 |
| David Hovda | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.